Tenerife-Based Hospiten Fuels Global Growth With Innovation Drive
Hospiten, a hospital group originating in Tenerife, is driving a global expansion and innovation strategy focused on advanced medical training, research, and technology, exemplified by new facilities like the Hospiten Madrid Boadilla Hospital.
Hospiten, a hospital group that started in Tenerife, is changing how it manages healthcare. It's doing this through a big plan to grow and innovate. This plan involves major projects designed to strengthen its position in Spain and worldwide, with a strong focus on training and research.
A great example of this new direction is the Hospiten Madrid Boadilla Hospital, set to open this year. This new hospital will work with the European University of Madrid, offering university internships and degree programs. It will have special labs for areas like Genomics and Bioengineering, focusing on new technologies. On top of that, it will feature an International Training Unit for Minimally Invasive and Robotic Surgery, teaching medical professionals from all over the world.
This project shows Hospiten's dedication to attracting top medical talent and creating new knowledge. By combining university education, scientific research, and complex medical care, Hospiten aims to build a system based on proven methods, specialized skills, and advanced technology. This will provide ongoing career development in a modern, international setting.
Hospiten started in Tenerife with Clínica Bellevue, now called Hospiten Bellevue University Hospital. From the beginning, the group focused on adapting, being efficient, and having a clear international outlook. It adopted a multicultural approach and flexible operations to serve both local residents and patients from abroad. Its base in the Canary Islands has been key to its growth. Hospiten remains committed to the islands by creating jobs and investing in facilities and new ideas. From the Canary Islands, Hospiten has expanded its healthcare model to Europe and America, becoming a leader in international medical services, with all management still based in Tenerife.
Today, Hospiten has centers in Spain in Tenerife, Gran Canaria, Lanzarote, Málaga, and Madrid. Internationally, it operates in the Dominican Republic, Mexico, Jamaica, and Panama. For research, its Phase I Clinical Trials Unit at MD Anderson Cancer Center Madrid - Hospiten is notable, recognized as one of the most important in Spain and Europe. The group also helps modernize the Canary Islands' healthcare system digitally, using robotics and artificial intelligence. This improves the region's technology and helps bring in the latest innovations.